{"entity":{"id":"nct05862610","kind":"trial","name":"The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC","aka":[],"tldr":"A phase 2 trial of trilaciclib in triple-negative breast cancer, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, not yet recruiting.","summary":"The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC is a phase 2, randomised interventional study registered as NCT05862610 by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, with a registry enrolment figure of 150 participants, started 2023-07-30 and due to reach its primary completion in 2026-12-30. Interventions recorded: Trilaciclib plus chemotherapy; Chemotherapy. Conditions listed: Breast Neoplasm. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05862610","url":"https://clinicaltrials.gov/study/NCT05862610"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":["trilaciclib"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05862610","phase":"2","setting":"A Prospective, Randomized, Controlled Phase II Clinical Study of Trilaciclib Combined With Standard Treatment Project As a Neoadjuvant Treatment For Triple Negative Breast Cancer","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","enrolled":150,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05862610/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"drug":[{"id":"trilaciclib","kind":"drug","name":"Trilaciclib","route":"/drugs/trilaciclib/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}